Fabienne Venet

14.5k total citations · 1 hit paper
163 papers, 7.4k citations indexed

About

Fabienne Venet is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Fabienne Venet has authored 163 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Immunology, 99 papers in Epidemiology and 35 papers in Molecular Biology. Recurrent topics in Fabienne Venet's work include Sepsis Diagnosis and Treatment (90 papers), Immune Response and Inflammation (86 papers) and Immune Cell Function and Interaction (21 papers). Fabienne Venet is often cited by papers focused on Sepsis Diagnosis and Treatment (90 papers), Immune Response and Inflammation (86 papers) and Immune Cell Function and Interaction (21 papers). Fabienne Venet collaborates with scholars based in France, United States and United Kingdom. Fabienne Venet's co-authors include Guillaume Monneret, Alain Lepape, Alexandre Pachot, Alfred Ayala, Chun‐Shiang Chung, Jacques Bienvenu, Anne‐Lise Debard, Julien Bohé, Julien Bohé and Julie Demaret and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fabienne Venet

156 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in the understanding and treatment of sepsis-induced immunosuppression

2017 627 citations Fabienne Venet, Guillaume Monneret profile →

Peers

Countries citing papers authored by Fabienne Venet

Since Specialization

Citations

This map shows the geographic impact of Fabienne Venet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabienne Venet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabienne Venet more than expected).

Fields of papers citing papers by Fabienne Venet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabienne Venet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabienne Venet. The network helps show where Fabienne Venet may publish in the future.

Co-authorship network of co-authors of Fabienne Venet

This figure shows the co-authorship network connecting the top 25 collaborators of Fabienne Venet. A scholar is included among the top collaborators of Fabienne Venet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabienne Venet. Fabienne Venet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic Clustering Analysis of Neutrophil to Lymphocyte Ratio Evolution Overtime in Intensive Care Unit Patients 2025 ·Medical Research Archives ·Ángela Restrepo, (unknown), (unknown), Morgane Gossez, Anne‐Claire Lukaszewicz, Thomas Rimmelé, Fabienne Venet, (unknown)	0
2	Immune profiling of critically ill patients with acute kidney injury during the first week after various types of injuries: the REALAKI study 2024 ·Critical Care ·(unknown), (unknown), (unknown), Fabienne Venet, Guillaume Monneret, Anne‐Claire Lukaszewicz, Jean‐François Llitjos, Julien Textoris, Thomas Rimmelé	6
3	Joint modeling of monocyte HLA‐DR expression trajectories predicts 28‐day mortality in severe SARS‐CoV‐2 patients 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Coralie Tardivon, Guillaume Monneret, Martin Cour, Thomas Rimmelé, Lorna Garnier, Hodane Yonis, Jean‐Christophe Richard, (unknown), Morgane Gossez, Florent Wallet, (unknown), Frédéric Dailler, (unknown), Anne‐Claire Lukaszewicz, Laurent Argaud, Cédric Laouenan, Julie Bertrand, Fabienne Venet, (unknown)	1
4	Interferon-Gamma-Release assay and absolute CD8 lymphocyte count for acquired immunosuppression monitoring in critically ill patients 2023 ·Cytokine ·(unknown), Fabienne Venet, Anne‐Claire Lukaszewicz, Estelle Peronnet, Elisabeth Cerrato, Thomas Rimmelé, Guillaume Monneret	4
5	Fully automated interferon-γ release assay to monitor antigen-independent T cell functionality: A proof of concept study in septic shock 2023 ·Cytokine ·(unknown), Soizic Daniel, Fabienne Venet, (unknown), Martin Cour, (unknown), Laurent Argaud, Anne‐Claire Lukaszewicz, (unknown), Guillaume Monneret	4
6	Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio 2023 ·Frontiers in Physiology ·(unknown), (unknown), (unknown), Morgane Gossez, (unknown), (unknown), Térésa Antonini, (unknown), Fabien Zoulim, Jean‐Yves Mabrut, Jérôme Dumortier, Fabienne Venet, Fanny Lebossé, Guillaume Monneret	2
7	Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries—Insights from the REALISM Study 2021 ·Journal of Clinical Medicine ·(unknown), (unknown), Fabienne Venet, Anne‐Claire Lukaszewicz, Karen Brengel‐Pesce, Filippo Conti, Laurence Quéméneur, Philippe Leissner, Lionel Tan, Julien Textoris, Thomas Rimmelé, Guillaume Monneret, (unknown)	14
8	Immune Profiling Panel: A Proof-of-Concept Study of a New Multiplex Molecular Tool to Assess the Immune Status of Critically Ill Patients 2020 ·The Journal of Infectious Diseases ·(unknown), Laurence Vachot, (unknown), Fabienne Venet, Thomas Rimmelé, Guillaume Monneret, Sophie Blein, Jesse Montgomery, Andrew Hemmert, Alexandre Pachot, Virginie Moucadel, (unknown), Karen Brengel‐Pesce, François Mallet, Julien Textoris	13
9	Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient 2020 ·Cellular and Molecular Immunology ·Guillaume Monneret, (unknown), (unknown), (unknown), Florence Ader, Émilie Frobert, Morgane Gossez, Sébastien Viel, Fabienne Venet, Florent Wallet	40
10	Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock 2020 ·In Silico Biology ·(unknown), Barbara Browning, Françoise Couenne, Claire Bordes, Fabienne Venet, Patrice Nony, François Gueyffier, Virginie Moucadel, Guillaume Monneret, Mélaz Tayakout‐Fayolle	4
11	The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients 2017 ·BMJ Open ·(unknown), Fabienne Venet, Thomas Rimmelé, Virginie Moucadel, Pierre Cortez, Laurence Quéméneur, David Gardiner, Andrew D. Griffiths, Alexandre Pachot, Julien Textoris, Guillaume Monneret	34
12	Danger associated molecular patterns in injury: a double-edged sword? 2016 ·Journal of Thoracic Disease ·Guillaume Monneret, Fabienne Venet, Martin Cour, Laurent Argaud	1
13	An optimized protocol for adenosine triphosphate quantification in T lymphocytes of lymphopenic patients 2016 ·Journal of Immunological Methods ·Thibaut Girardot, (unknown), (unknown), (unknown), (unknown), Thomas Rimmelé, Guillaume Monneret, Julien Textoris, Fabienne Venet	2
14	Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial 2015 ·Critical Care ·Fabienne Venet, Jonathan Plassais, Julien Textoris, Marie-Angélique Cazalis, Alexandre Pachot, M. Bertin‐Maghit, C. Magnin, Thomas Rimmelé, Guillaume Monneret, S. Tissot	25
15	Relationship between discordant response to HAART, Tregs, immune activation and low‐level viraemia 2014 ·Journal of the International AIDS Society ·Julien Saison, Tristan Ferry, Julie Demaret, Delphine Maucort‐Boulch, Fabienne Venet, Thomas Perpoint, Florence Ader, Vinca Icard, Christian Chidiac, (unknown)	6
16	PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis 2009 ·Proceedings of the National Academy of Sciences ·Xin Huang, Fabienne Venet, (unknown), Alain Lepape, Zhenglong Yuan, Yaping Chen, Ryan Z. Swan, (unknown), Guillaume Monneret, Chun‐Shiang Chung, Alfred Ayala	420
17	The Role of Hepatic Invariant NKT Cells in Systemic/Local Inflammation and Mortality during Polymicrobial Septic Shock 2009 ·The Journal of Immunology ·Caroline K. Hu, Fabienne Venet, Daithi S. Heffernan, (unknown), (unknown), Xin Huang, Chun‐Shiang Chung, Stephen H. Gregory, Alfred Ayala	50
18	Lymphocytes in the Development of Lung Inflammation: A Role for Regulatory CD4+ T Cells in Indirect Pulmonary Lung Injury 2009 ·The Journal of Immunology ·Fabienne Venet, Chun‐Shiang Chung, Xin Huang, Joanne Lomas‐Neira, Yaping Chen, Alfred Ayala	63
19	Decreased Expression of the Fractalkine Receptor CX3CR1 on Circulating Monocytes as New Feature of Sepsis-Induced Immunosuppression 2008 ·The Journal of Immunology ·Alexandre Pachot, Marie-Angélique Cazalis, Fabienne Venet, (unknown), (unknown), Nicolas Voirin, (unknown), (unknown), Françoise Poitevin, (unknown), Alain Lepape, Guillaume Monneret	91
20	Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism 2006 ·The Journal of Immunology ·Fabienne Venet, Alexandre Pachot, Anne‐Lise Debard, Julien Bohé, Jacques Bienvenu, Alain Lepape, William S. Powell, Guillaume Monneret	124

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact